Kawasaki Disease: A Never-ending Story?

被引:2
|
作者
Lianza, Alessandro Cavalcanti [1 ,2 ,3 ]
Diniz, Maria de Fatima Rodrigues [1 ,4 ]
Sawamura, Karen Saori Shiraishi [1 ,2 ,3 ]
Menezes, Carolina da Rocha Brito [1 ,5 ]
Silva, Isabela de Sousa Lobo [1 ,6 ]
Leal, Gabriela Nunes [1 ,2 ,4 ,7 ]
机构
[1] Hosp Clin Univ Sao Paulo, Echocardiog Lab, Inst Crianca & Adolescente, Sao Paulo, Brazil
[2] Hosp Coracao Sao Paulo, Dept Paediat & Foetal Echocardiog, Sao Paulo, Brazil
[3] Hosp Israelita Albert Einstein, Dept Paediat & Foetal Echocardiog, Sao Paulo, Brazil
[4] Hosp Sirio Libanes, Dept Paediat & Foetal Echocardiog, Sao Paulo, Brazil
[5] Maternidade Sao Luiz Star, Dept Paediat & Foetal Echocardiog, Sao Paulo, Brazil
[6] Hosp Samaritano, Dept Paediat Cardiol, Sao Paulo, Brazil
[7] Hosp Clin Univ Sao Paulo, Inst Crianca & Adolescente, Av Dr Eneas Carvalho de Aguiar 647, BR-05403000 Sao Paulo, SP, Brazil
关键词
Kawasaki disease; cardiovascular risk factor; children; adults; CORONARY-ARTERY; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; MANAGEMENT; DIAGNOSIS; CHILDREN; SAFETY; ADULTS;
D O I
10.15420/ecr.2023.15
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The most severe complication of Kawasaki disease, an inflammatory disorder of young children, is the formation of coronary artery aneurysms. It is known that patients with coronary artery aneurysms, particularly those with medium and large lesions, have a higher risk of future major cardiovascular events. In contrast, there is a lack of data on the cardiovascular status in long-term follow-up for Kawasaki disease patients without coronary involvement or with self-limited coronary artery aneurysms, resulting in most patients being discharged after 5 years. Even though some paediatricians may believe these patients should not be followed at all, studies indicating a dysfunctional endothelium show the need for further investigation. Consequently, a review of the most significant aspects of Kawasaki disease, and the necessity of correctly identifying, treating and monitoring these patients, particularly those with a higher risk of complications, was conducted.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Sarin: a never-ending story
    Hermann M. Bolt
    [J]. Archives of Toxicology, 2023, 97 : 1 - 2
  • [22] LNT: a never-ending story
    Anna A. Friedl
    Werner Rühm
    [J]. Radiation and Environmental Biophysics, 2006, 44 : 241 - 244
  • [23] Sarin: a never-ending story
    Bolt, Hermann M.
    [J]. ARCHIVES OF TOXICOLOGY, 2023, 97 (01) : 1 - 2
  • [24] TRIAZOLAM - THE NEVER-ENDING STORY
    PERRY, PJ
    SMITH, DA
    [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (11): : 1263 - 1264
  • [25] The never-ending (graphics) story
    Dipert, B
    [J]. EDN, 2000, 45 (09) : 24 - 24
  • [26] Laccases: a never-ending story
    Giardina, Paola
    Faraco, Vincenza
    Pezzella, Cinzia
    Piscitelli, Alessandra
    Vanhulle, Sophie
    Sannia, Giovanni
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (03) : 369 - 385
  • [27] The never-ending story of justification
    Taliga, Milos
    [J]. FILOSOFICKY CASOPIS, 2009, 57 (03): : 353 - 374
  • [28] Luminescence: The Never-Ending Story
    Nicola Armaroli
    Henk J. Bolink
    [J]. Topics in Current Chemistry, 2016, 374
  • [29] Luminescence: The Never-Ending Story
    Armaroli, Nicola
    Bolink, Henk J.
    [J]. TOPICS IN CURRENT CHEMISTRY, 2016, 374 (04)
  • [30] Serotonin: A never-ending story
    Olivier, Berend
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 753 : 2 - 18